Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesIntravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Cochrane Reviews, 07/13/09
Fortin PM et al. - Intravenous immunoglobulin (IVIg) is an expensive and fairly rare blood product that has been used to treat Wegener's granulomatosis but its effects on the disorder are unknown. The authors asked if IVIg provided an advantage as an additive to standard treatments. The authors found one small randomized trial in which 34 particpants were randomized to receive IVIg or placebo once daily in addition to azathioprine and prednisolone for remission maintenance. This trial did not provide enough evidence to determine if IVIg has an advantage over corticosteroids and immunosuppressants for the treatment of Wegener's granulomatosis.
Related Articles
Surgical interventions and local therapy for Wegeners granulomatosis
Current Opinion in Rheumatology, 11/17/09
Relevance Score: 69%
T-Lymphocytes and Disease Mechanisms in Wegener's Granulomatosis
Kidney and Blood Pressure Research, 11/09/09
Relevance Score: 66%
Increased accumulation of advanced glycation endproducts in patients with Wegeners granulomatosis
Annals of Rheumatic Diseases, 11/11/09
Relevance Score: 65%
Recent progress in the genetics of Wegeners granulomatosis and Churg-Strauss syndrome
Current Opinion in Rheumatology, 10/30/09
Relevance Score: 65%
Successful treatment of hypertrophic pachymeningitis in refractory Wegeners granulomatosis with rituximab
Clinical Rheumatology, 10/15/09
Relevance Score: 65%
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria
Annals of Allergy, Asthma, and Immunology, 12/16/09
The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
Journal of Immunology, 12/16/09
The sympathetic nervous system modulates CD4+FoxP3+ regulatory T cells via a TGF-[beta]-dependent mechanism
Journal of Leukocyte Biology, 12/16/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/16/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/16/09
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor